CSL - Fremdkapital

Aktienkurs
125.93
Täglich Wechseln
-2.97 -2.30%
Monatlich
-10.57%
Jährlich
-49.85%
Q2 Prognose
127.56




Fremdkapital Veränderung Datum
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
aTyr Pharma USD 12.51M 12.11M 2025-12
Bio Path USD 0 0 2025-03
Brainstorm Cell Therapeutics USD 0 0 2025-03
Cara Therapeutics USD 0 0 2025-03
CSL USD 10.42B 273M 2025-12
Curis USD 29.43M 10.69M 2024-06
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Immunic USD 0 0 2024-06
Infinity Pharmaceuticals USD 0 0 2022-06
Minerva Neurosciences USD 0 86.58M 2024-09
Sangamo BioSciences USD 0 0 2022-06
TherapeuticsMD USD 0 0 2022-03